The regulatory framework for commercialisation of medical and health products continue to evolve with innovation developments and increasing health and environmental concerns. While these changes present challenges for businesses, they also generate new opportunities. To help local enterprises in the Health and Personal Care industry better understand new regulatory requirements and identify potential opportunities arising from regulatory updates, IPI organised the Stamp of Approval: Certification and Compliance forum on 4 September 2019.
The event drew over 100 participants from the Biomedical Sciences, Chemicals, Electronics and Personal Care industries, including heads of R&D and product development. Attendees acquired valuable knowledge on global medical device regulatory requirements and networks to navigate regulatory complexities from guest speakers Ken Simpson, Principal Patent Attorney of Davies Collison Cave, Bernice Lau, Medical and Health Service Executive Auditor of TÜV SÜD PSB and Jack Wong, Founder of Asia Regulatory Professional Association.
The speakers shared ways to create stronger IP to support their businesses with the adoption of emerging technologies such as AI. In addition, they also highlighted global medical device regulatory requirements, and testing and compliance considerations for healthcare product registrations in Asia. The event closed with a panel discussion on regulations and compliance issues surrounding smart medtech devices and personal and consumer care innovations, moderated by IPI Deputy Director Sim Kung Kiat.
